Visual Erotica, EMG, and Sexual Psychophysiological Arousal (VESPA) (VESPA)

May 30, 2017 updated by: Lori Brotto, University of British Columbia
This study will examine whether measurement of pelvic floor muscle sEMG activity is responsive to explicit sexual stimuli, and whether it correlates with self-reports of sexual arousal in healthy women. Participants' vaginal, labial and anal sEMG readings will be monitored during exposure to neutral, erotic and anxiety-provoking films. Participants will also be required to provide subjective ratings of sexual arousal before and after each film. If pelvic floor sEMG is validated as a psychophysiological measure, these findings may have important clinical and research implications by providing a greater understanding of the mechanisms involved in sexual arousal and for providing a relatively easy method of assessing sexual arousal in a clinical or research setting.

Study Overview

Status

Completed

Conditions

Detailed Description

HYPOTHESES:

  1. Investigators hypothesize that, relative to the neutral films, PFM EMG activity will significantly increase in response to the erotic film as measured by the labial, anal, and vaginal EMG probes.
  2. Investigators hypothesize that, relative to the anxiety-provoking film, PFM EMG activity will significantly increase in response to the erotic film as measured by the labial, anal, and vaginal EMG probes.
  3. Investigators hypothesize that continuously measured subjective sexual arousal (via the arousometer) will correlate significantly with PFM EMG activity during the erotic film.

Study Type

Observational

Enrollment (Actual)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 1M9
        • Department of Gynaecology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 41 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Healthy females.

Description

Inclusion Criteria:

  • Must be female, between the ages of 19-45
  • Must be premenopausal
  • Must be previously sexually active
  • Must be fluent in English

Exclusion Criteria:

  • Lack of fluency in English
  • Not female between the ages of 19-45
  • Not previously sexually active
  • Any previous deliveries, either vaginal or by c-section
  • Any sexual arousal disorder
  • Any genital pain or pelvic pain disorders
  • Any bowel or bladder syndromes (e.g. interstitial cystitis, irritable bowel disease, Chron's disease)
  • Any urinary incontinence or pelvic organ prolapse
  • Undergone medically induced menopause
  • Undergone total or partial hysterectomy
  • Undergone surgery for incontinence or prolapse
  • Using estrogen suppression medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
No treatment
This is an observational study. Women in this study are not receiving any treatments.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pelvic floor muscle sEMG activity
Time Frame: This study involves 1 testing session approximately 20 minutes in duration
Changes in pelvic floor muscle activity in responsive to exposure to explicit sexual stimuli will be assessed using pelvic floor surface electromyography (sEMG).
This study involves 1 testing session approximately 20 minutes in duration

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexual Arousal
Time Frame: This study involves 1 testing session approximately 20 minutes in duration
Self-report sexual arousal will be measured with the Sexual Arousability Inventory (SAI ; Hoon, Hoon, & Wincze, 1976)
This study involves 1 testing session approximately 20 minutes in duration
Sexual Function
Time Frame: This study involves 1 testing session approximately 20 minutes in duration
Self-reported sexual function will be measured using the Female Sexual Function Inventory (FSFI; Rosen et al., 2000) and the Derogatis Sexual Functioning Inventory (DSFI; Derogatis & Melisaratos, 1979).
This study involves 1 testing session approximately 20 minutes in duration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lori A. Brotto, PhD, University of British Columbia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

February 1, 2013

Study Completion (Actual)

February 1, 2013

Study Registration Dates

First Submitted

August 27, 2012

First Submitted That Met QC Criteria

October 1, 2012

First Posted (Estimate)

October 4, 2012

Study Record Updates

Last Update Posted (Actual)

June 1, 2017

Last Update Submitted That Met QC Criteria

May 30, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • H12-01852

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Arousal

Subscribe